Financial Conflict Of Interest FDA Surveillance Must Increase - Henney
This article was originally published in The Tan Sheet
Executive Summary
Increased surveillance of financial conflict of interest is necessary to guard against bias or the perception of bias, FDA Commissioner Jane Henney, MD, indicated at an HHS meeting on human subject protection and financial conflict of interest Aug. 15 at the National Institutes of Health.
You may also be interested in...
IoM Research Review Program Certification Standards Slated For April
The Institute of Medicine will create national uniform standards for accreditation of human research review programs by April 2001 under a contract with HHS.
IoM Research Review Program Certification Standards Slated For April
The Institute of Medicine will create national uniform standards for accreditation of human research review programs by April 2001 under a contract with HHS.
IoM Research Review Program Certification Standards Slated For April
The Institute of Medicine will create national uniform standards for accreditation of human research review programs by April 2001 under a contract with HHS.